Tag: paclitaxelTaxol

Articles

• Foods to eat and avoid during Taxol chemotherapy

News

04/21/18

Quercetin can reverse chemotherapy resistance in ER+/PR+ BC cells

03/12/17

Sulforaphane in broccoli heightens taxane effects against TN disease

02/22/15

Blueberry and ginger compounds enhance Taxol treatment effects

05/31/13

Black pepper compound increases effectiveness of Taxol in HER2+ BC

02/22/12

Selenium increases effectiveness of Taxol for TN breast cancer

01/17/12

Apigenin increases effectiveness of Taxol chemotherapy

12/26/10

Muscle and joint pain are common during taxane chemotherapy

Studies

• Development and evaluation of folate-gelatin-poloxamer P407 copolymer nanogels for enhanced co-delivery of paclitaxel and curcumin in breast cancer therapy Cite
  Ly HQ, Nguyen QT, Vu HP, Nguyen VT. Development and evaluation of folate-gelatin-poloxamer P407 copolymer nanogels for enhanced co-delivery of paclitaxel and curcumin in breast cancer therapy. Colloid and Polymer Science. Springer Science and Business Media LLC; 2024; 10.1007/s00396-024-05346-8
• Enhanced Synergistic Efficacy Against Breast Cancer Cells Promoted by Co-Encapsulation of Piplartine and Paclitaxel in Acetalated Dextran Nanoparticles Cite
  Braga CB, Perli G, Fonseca R, Grigolo TA, Ionta M, Ornelas C, et al. Enhanced Synergistic Efficacy Against Breast Cancer Cells Promoted by Co-Encapsulation of Piplartine and Paclitaxel in Acetalated Dextran Nanoparticles. Molecular Pharmaceutics. American Chemical Society (ACS); 2024; 10.1021/acs.molpharmaceut.4c00548
• Therapeutic Applications of Rosmarinic Acid in Cancer-Chemotherapy-Associated Resistance and Toxicity Cite
  Villegas C, Cortez N, Ogundele AV, Burgos V, Pardi PC, Cabrera-Pardo JR, et al. Therapeutic Applications of Rosmarinic Acid in Cancer-Chemotherapy-Associated Resistance and Toxicity. Biomolecules. MDPI AG; 2024; 14:867 10.3390/biom14070867
• Enhanced Apoptotic Effects in MDA-MB-231 Triple-Negative Breast Cancer Cells Through a Synergistic Action of Luteolin and Paclitaxel Cite
  Tamanna S, Perumal E, Rajanathadurai J. Enhanced Apoptotic Effects in MDA-MB-231 Triple-Negative Breast Cancer Cells Through a Synergistic Action of Luteolin and Paclitaxel. Cureus. Springer Science and Business Media LLC; 2024; 10.7759/cureus.65159
• Differential effects of docosahexaenoic acid (DHA) and linoleic acid (LA) on miR-101 and miR-342 tumor suppressor microRNAs in Taxol-treated HER2-positive breast cancer cells Cite
  Aslan C, Maralbashi S, Shekari N, Javadian M, Shomali N, Kazemi T. Differential effects of docosahexaenoic acid (DHA) and linoleic acid (LA) on miR-101 and miR-342 tumor suppressor microRNAs in Taxol-treated HER2-positive breast cancer cells. Clinical Nutrition ESPEN. Elsevier BV; 2024; 63:502-507 10.1016/j.clnesp.2024.07.007
• Harnessing Potential of ω-3 Polyunsaturated Fatty Acid with Nanotechnology for Enhanced Breast Cancer Therapy: A Comprehensive Investigation into ALA-Based Liposomal PTX Delivery Cite
  Kumar R, Kumar A, Kumar D, Yadav S, Shrivastava NK, Singh J, et al. Harnessing Potential of ω-3 Polyunsaturated Fatty Acid with Nanotechnology for Enhanced Breast Cancer Therapy: A Comprehensive Investigation into ALA-Based Liposomal PTX Delivery. Pharmaceutics. MDPI AG; 2024; 16:913 10.3390/pharmaceutics16070913
• Chemotherapy-induced gut microbiome disruption, inflammation, and cognitive decline in female patients with breast cancer Cite
  Otto-Dobos L, Grant C, Lahoud A, Wilcox O, Strehle L, Loman B, et al. Chemotherapy-induced gut microbiome disruption, inflammation, and cognitive decline in female patients with breast cancer. Brain, Behavior, and Immunity. Elsevier BV; 2024; 120:208-220 10.1016/j.bbi.2024.05.039
• Celecoxib Augments Paclitaxel-Induced Immunogenic Cell Death in Triple-Negative Breast Cancer Cite
  Qian X, Yang H, Ye Z, Gao B, Qian Z, Ding Y, et al. Celecoxib Augments Paclitaxel-Induced Immunogenic Cell Death in Triple-Negative Breast Cancer. ACS Nano. American Chemical Society (ACS); 2024; 10.1021/acsnano.4c02947
• Potential of Natural Phenolic Compounds against Doxorubicin-Induced Chemobrain: Biological and Molecular Mechanisms Involved Cite
  Serini S, Calviello G. Potential of Natural Phenolic Compounds against Doxorubicin-Induced Chemobrain: Biological and Molecular Mechanisms Involved. Antioxidants. MDPI AG; 2024; 13:486 10.3390/antiox13040486
• Targeting CD73 with flavonoids inhibits cancer stem cells and increases lymphocyte infiltration in a triple-negative breast cancer mouse model Cite
  Mediratta K, El-Sahli S, Marotel M, Awan MZ, Kirkby M, Salkini A, et al. Targeting CD73 with flavonoids inhibits cancer stem cells and increases lymphocyte infiltration in a triple-negative breast cancer mouse model. Frontiers in Immunology. Frontiers Media SA; 2024; 15 10.3389/fimmu.2024.1366197
• Metformin as anticancer agent and adjuvant in cancer combination therapy: Current progress and future prospect Cite
  Zhu L, Yang K, Ren Z, Yin D, Zhou Y. Metformin as anticancer agent and adjuvant in cancer combination therapy: Current progress and future prospect. Translational Oncology. Elsevier BV; 2024; 44:101945 10.1016/j.tranon.2024.101945
• The Potential of Mushroom Extracts to Improve Chemotherapy Efficacy in Cancer Cells: A Systematic Review Cite
  Fonseca J, Vaz JA, Ricardo S. The Potential of Mushroom Extracts to Improve Chemotherapy Efficacy in Cancer Cells: A Systematic Review. Cells. MDPI AG; 2024; 13:510 10.3390/cells13060510
• Computational and in vitro analyses on synergistic effects of paclitaxel and thymoquinone in suppressing invasive breast cancer cells Cite
  Khazaei MR, Bozorgi M, Khazaei M, Moradi A, Bozorgi A. Computational and in vitro analyses on synergistic effects of paclitaxel and thymoquinone in suppressing invasive breast cancer cells. Molecular Biology Reports. Springer Science and Business Media LLC; 2024; 51 10.1007/s11033-024-09328-5
• Statins inhibit paclitaxel-induced PD-L1 expression and increase CD8+ T cytotoxicity for better prognosis in breast cancer Cite
  Li L, Wang H, Zhang S, Gao S, Lu X, Pan Y, et al. Statins inhibit paclitaxel-induced PD-L1 expression and increase CD8+ T cytotoxicity for better prognosis in breast cancer. International Journal of Surgery. Ovid Technologies (Wolters Kluwer Health); 2024; 10.1097/js9.0000000000001582
• Efficient and controllable co-delivery of paclitaxel and curcumin from fucoidan-pluronic F127 nanogel for synergistic breast cancer treatment Cite
  Nguyen NT, Nguyen VT, Vu TT, Le Nguyen TV, Nguyen TTT, Huynh PD, et al. Efficient and controllable co-delivery of paclitaxel and curcumin from fucoidan-pluronic F127 nanogel for synergistic breast cancer treatment. Macromolecular Research. Springer Science and Business Media LLC; 2024; 10.1007/s13233-023-00240-8
• Harnessing Sulforaphane Potential as a Chemosensitizing Agent: A Comprehensive Review Cite
  Sailo BL, Liu L, Chauhan S, Girisa S, Hegde M, Liang L, et al. Harnessing Sulforaphane Potential as a Chemosensitizing Agent: A Comprehensive Review. Cancers. MDPI AG; 2024; 16:244 10.3390/cancers16020244
• Novel Anti-tumor Strategy for Breast Cancer: Synergistic Role of Oleuropein with Paclitaxel Therapeutic in MCF-7 Cell Cite
  Yılmaz G, Özdemir F. Novel Anti-tumor Strategy for Breast Cancer: Synergistic Role of Oleuropein with Paclitaxel Therapeutic in MCF-7 Cell. Anti-Cancer Agents in Medicinal Chemistry. Bentham Science Publishers Ltd.; 2023; 23 10.2174/0118715206284107231120063630
• Caffeine Increased Antitumor Effects of Paclitaxel (PTX) in MCF-7 and MDA-MB-231 Breast Cancer Cells Cite
  AYDIN F, ÖNDER GÖ, GÖKTEPE Ö, BİTGEN N. Caffeine Increased Antitumor Effects of Paclitaxel (PTX) in MCF-7 and MDA-MB-231 Breast Cancer Cells. Journal of Research in Pharmacy. ASOS Yayinevi; 2023; 27(6):2242-2249 10.29228/jrp.513
• Enhancing Paclitaxel Efficacy with Piperine-Paclitaxel Albumin Nanoparticles in Multidrug-Resistant Triple-Negative Breast Cancer by Inhibiting P-Glycoprotein Cite
  Xu W, Xiao Y, Zheng L, Xu M, Jiang X, Wang L. Enhancing Paclitaxel Efficacy with Piperine-Paclitaxel Albumin Nanoparticles in Multidrug-Resistant Triple-Negative Breast Cancer by Inhibiting P-Glycoprotein. Pharmaceutics. MDPI AG; 2023; 15:2703 10.3390/pharmaceutics15122703
• Vitamin D Insufficiency as a Risk Factor for Paclitaxel-Induced Peripheral Neuropathy in SWOG S0221 Cite
  Chen C, Zirpoli G, Barlow WE, Budd GT, McKiver B, Pusztai L, et al. Vitamin D Insufficiency as a Risk Factor for Paclitaxel-Induced Peripheral Neuropathy in SWOG S0221. Journal of the National Comprehensive Cancer Network. Harborside Press, LLC; 2023; 21:1172-1180.e3 10.6004/jnccn.2023.7062
• Efficacy of metformin in prevention of paclitaxel-induced peripheral neuropathy in breast cancer patients: a randomized controlled trial Cite
  Bakry HM, Mansour NO, ElKhodary TR, Soliman MM. Efficacy of metformin in prevention of paclitaxel-induced peripheral neuropathy in breast cancer patients: a randomized controlled trial. Frontiers in Pharmacology. Frontiers Media SA; 2023; 14 10.3389/fphar.2023.1181312
• A study on concurring effect of paclitaxel and thymoquinone on MCF-7 cell line – In vitro Cite
  Anandan I, Gokul T, K N, Elango A, Vivekkumar P. A study on concurring effect of paclitaxel and thymoquinone on MCF-7 cell line – In vitro. National Journal of Physiology, Pharmacy and Pharmacology. ScopeMed; 2023;:1 10.5455/njppp.2023.13.09428202319092023
• Short-term fasting and fasting mimicking diets combined with chemotherapy: a narrative review Cite
  Kikomeko J, Schutte T, van Velzen MJ, Seefat R, van Laarhoven HW. Short-term fasting and fasting mimicking diets combined with chemotherapy: a narrative review. Therapeutic Advances in Medical Oncology. SAGE Publications; 2023; 15:175883592311614 10.1177/17588359231161418
• Chemotherapy induced peripheral neuropathy (CIPN) due to paclitaxel versus docetaxel in patients with early-stage breast cancer receiving taxane therapy: SWOG S1714. Cite
  Trivedi MS, Unger JM, Hershman DL, Darke A, Hertz DL, Brannagan T, et al. Chemotherapy induced peripheral neuropathy (CIPN) due to paclitaxel versus docetaxel in patients with early-stage breast cancer receiving taxane therapy: SWOG S1714.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2023; 41:12003-12003 10.1200/jco.2023.41.16_suppl.12003
• Potential from synergistic effect of quercetin and paclitaxel co-encapsulated in the targeted folic–gelatin–pluronic P123 nanogels for chemotherapy Cite
  Nguyen DT, Nguyen TP, Dinh VT, Nguyen NH, Nguyen KTH, Nguyen TH, et al. Potential from synergistic effect of quercetin and paclitaxel co-encapsulated in the targeted folic–gelatin–pluronic P123 nanogels for chemotherapy. International Journal of Biological Macromolecules. Elsevier BV; 2023; 243:125248 10.1016/j.ijbiomac.2023.125248
• Exploring the mechanism by which quercetin re-sensitizes breast cancer to paclitaxel: network pharmacology, molecular docking, and experimental verification Cite
  Yang Y, Yan J, Huang J, Wu X, Yuan Y, Yuan Y, et al. Exploring the mechanism by which quercetin re-sensitizes breast cancer to paclitaxel: network pharmacology, molecular docking, and experimental verification. Naunyn-Schmiedeberg's Archives of Pharmacology. Springer Science and Business Media LLC; 2023; 10.1007/s00210-023-02510-9
• Rutin and Hesperidin Alleviate Paclitaxel-Induced Nephrocardiotoxicity in Wistar Rats via Suppressing the Oxidative Stress and Enhancing the Antioxidant Defense Mechanisms Cite
  Ali YA, Ahmed OM, Soliman HA, Abdel-Gabbar M, Al-Dossari M, El-Gawaad NSA, et al. Rutin and Hesperidin Alleviate Paclitaxel-Induced Nephrocardiotoxicity in Wistar Rats via Suppressing the Oxidative Stress and Enhancing the Antioxidant Defense Mechanisms. Evidence-Based Complementary and Alternative Medicine. Hindawi Limited; 2023; 2023:1-15 10.1155/2023/5068304
• 10-Gingerol Enhances the Effect of Taxol in Triple-Negative Breast Cancer via Targeting ADRB2 Signaling Cite
  Liang Y, Wu G, Luo T, Xie H, Zuo Q, Huang P, et al. 10-Gingerol Enhances the Effect of Taxol in Triple-Negative Breast Cancer via Targeting ADRB2 Signaling. Drug Design, Development and Therapy. Informa UK Limited; 2023; Volume 17:129-142 10.2147/dddt.s390602
• A review of the pharmacodynamic effect of chemo-herbal drug combinations therapy for cancer treatment Cite
  Okem A, Henstra C, Lambert M, Hayeshi R. A review of the pharmacodynamic effect of chemo-herbal drug combinations therapy for cancer treatment. Medicine in Drug Discovery. Elsevier BV; 2023; 17:100147 10.1016/j.medidd.2022.100147
• The Self-Administered Use of Complementary and Alternative Medicine (CAM) Supplements and Antioxidants in Cancer Therapy and the Critical Role of Nrf-2—A Systematic Review Cite
  Krejbich P, Birringer M. The Self-Administered Use of Complementary and Alternative Medicine (CAM) Supplements and Antioxidants in Cancer Therapy and the Critical Role of Nrf-2—A Systematic Review. Antioxidants. MDPI AG; 2022; 11:2149 10.3390/antiox11112149
• Glucose deprivation reduces proliferation and motility, and enhances the anti-proliferative effects of paclitaxel and doxorubicin in breast cell lines in vitro Cite
  Khajah MA, Khushaish S, Luqmani YA. Glucose deprivation reduces proliferation and motility, and enhances the anti-proliferative effects of paclitaxel and doxorubicin in breast cell lines in vitro. PLOS ONE. Public Library of Science (PLoS); 2022; 17:e0272449 10.1371/journal.pone.0272449
• Insight into drug sensitizing effect of diallyl disulfide and diallyl trisulfide from Allium sativum L. on paclitaxel-resistant triple-negative breast cancer cells Cite
  Marni R, Kundrapu DB, Chakraborti A, Malla R. Insight into drug sensitizing effect of diallyl disulfide and diallyl trisulfide from Allium sativum L. on paclitaxel-resistant triple-negative breast cancer cells. Journal of Ethnopharmacology. Elsevier BV; 2022; 296:115452 10.1016/j.jep.2022.115452
• Role of alpha-lipoic acid in counteracting paclitaxel- and doxorubicin-induced toxicities: a randomized controlled trial in breast cancer patients Cite
  Werida RH, Elshafiey RA, Ghoneim A, Elzawawy S, Mostafa TM. Role of alpha-lipoic acid in counteracting paclitaxel- and doxorubicin-induced toxicities: a randomized controlled trial in breast cancer patients. Supportive Care in Cancer. Springer Science and Business Media LLC; 2022; 10.1007/s00520-022-07124-0
• Protectins Inhibit Estrogen Receptor Negative Breast Cancer Growth in Mice Cite
  Kipper FC, Kelly A, Rothenberger E, Duncan M, Serhan CN, Panigrahy D. Protectins Inhibit Estrogen Receptor Negative Breast Cancer Growth in Mice. The FASEB Journal. Wiley; 2022; 36 10.1096/fasebj.2022.36.s1.r4640
• Zerumbone‐induced reactive oxygen species‐mediated oxidative stress re‐sensitizes breast cancer cells to paclitaxel Cite
  Li J, Wang L, Sun Y, Wang Z, Qian Y, Duraisamy V, et al. Zerumbone‐induced reactive oxygen species‐mediated oxidative stress re‐sensitizes breast cancer cells to paclitaxel. Biotechnology and Applied Biochemistry. Wiley; 2022; 10.1002/bab.2326
• Effect of turmeric supplementation on the pharmacokinetics of paclitaxel in breast cancer patients: A study with population pharmacokinetics approach Cite
  Kalluru H, Mallayasamy SR, Kondaveeti SS, Chandrasekhar V, Kalachaveedu M. Effect of turmeric supplementation on the pharmacokinetics of paclitaxel in breast cancer patients: A study with population pharmacokinetics approach. Phytotherapy Research. Wiley; 2022; 10.1002/ptr.7412
• T Cells Promote Metastasis by Regulating Extracellular Matrix Remodeling following Chemotherapy Cite
  Haj-Shomaly J, Vorontsova A, Barenholz-Cohen T, Levi-Galibov O, Devarasetty M, Timaner M, et al. T Cells Promote Metastasis by Regulating Extracellular Matrix Remodeling following Chemotherapy. Cancer Research. American Association for Cancer Research (AACR); 2021; 82:278-291 10.1158/0008-5472.can-21-1012
• Can Exposure to Environmental Pollutants Be Associated with Less Effective Chemotherapy in Cancer Patients? Cite
  Lagunas-Rangel FA, Liu W, Schiöth HB. Can Exposure to Environmental Pollutants Be Associated with Less Effective Chemotherapy in Cancer Patients?. International Journal of Environmental Research and Public Health. MDPI AG; 2022; 19:2064 10.3390/ijerph19042064
• The effect of trastuzumab on taxane-induced peripheral neuropathy in women with breast cancer: a population-based cohort study Cite
  Patel R, Lyne-Ethier J, Brogly S, Griffiths R, Hendry JM. The effect of trastuzumab on taxane-induced peripheral neuropathy in women with breast cancer: a population-based cohort study. Research Square Platform LLC; 2022; 10.21203/rs.3.rs-1254626/v1
• Beneficial effects of exercise on chemotherapy-induced peripheral neuropathy and sleep disturbance: A review of literature and proposed mechanisms Cite
  Brett Whalen L, Zachary Wright W, Kundur P, Angadi S, Modesitt SC. Beneficial effects of exercise on chemotherapy-induced peripheral neuropathy and sleep disturbance: A review of literature and proposed mechanisms. Gynecologic Oncology Reports. Elsevier BV; 2022; 39:100927 10.1016/j.gore.2022.100927
• Isoflavones in Soybean as a Daily Nutrient: The Mechanisms of Action and How They Alter the Pharmacokinetics of Drugs Cite
  SOYATA A, HASANAH AN, RUSDIANA T. Isoflavones in Soybean as a Daily Nutrient: The Mechanisms of Action and How They Alter the Pharmacokinetics of Drugs. Turkish Journal of Pharmaceutical Sciences. Galenos Yayinevi; 2021; 18:799-810 10.4274/tjps.galenos.2020.79106
• DEHP mediates drug resistance by directly targeting AhR in human breast cancer Cite
  Hsieh T, Hsu C, Yang P, Chiu C, Liang S, Ou-Yang F, et al. DEHP mediates drug resistance by directly targeting AhR in human breast cancer. Biomedicine & Pharmacotherapy. Elsevier BV; 2022; 145:112400 10.1016/j.biopha.2021.112400
• Impact of taxane-based chemotherapy among older women with breast cancer on cognition and quality of life: a longitudinal pooled analysis Cite
  Small BJ, Lange M, Zhai W, Ahn J, Ahles TA, Carroll JE, et al. Impact of taxane-based chemotherapy among older women with breast cancer on cognition and quality of life: a longitudinal pooled analysis. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-021-06455-6
• Efficacy of Resveratrol Against Advanced Breast Cancer-Derived Organoids: A comparison with that of Clinically Relevant Drugs Cite
  Ye H, Gao H, Li H, Nie J, Li T, Lu M, et al. Efficacy of Resveratrol Against Advanced Breast Cancer-Derived Organoids: A comparison with that of Clinically Relevant Drugs. Research Square Platform LLC; 2021; 10.21203/rs.3.rs-970702/v1
• The protective effects of hesperidin against paclitaxel-induced peripheral neuropathy in rats Cite
  Semis HS, Kandemir FM, Kaynar O, Dogan T, Arikan SM. The protective effects of hesperidin against paclitaxel-induced peripheral neuropathy in rats. Life Sciences. Elsevier BV; 2021; 287:120104 10.1016/j.lfs.2021.120104
• A careful reassessment of anthracycline use in curable breast cancer Cite
  Hurvitz SA, McAndrew NP, Bardia A, Press MF, Pegram M, Crown JP, et al. A careful reassessment of anthracycline use in curable breast cancer. npj Breast Cancer. Springer Science and Business Media LLC; 2021; 7 10.1038/s41523-021-00342-5
• Paclitaxel chemotherapy disrupts behavioral and molecular circadian clocks in mice Cite
  Sullivan KA, Grant CV, Jordan KR, Obrietan K, Pyter LM. Paclitaxel chemotherapy disrupts behavioral and molecular circadian clocks in mice. Brain, Behavior, and Immunity. Elsevier BV; 2021; 10.1016/j.bbi.2021.09.011
• Docosahexaenoic acid (DHA) and linoleic acid (LA) modulate the expression of breast cancer involved miRNAs in MDA-MB-231 cell line Cite
  Elieh Ali Komi D, Shekari N, Soofian-kordkandi P, Javadian M, Shanehbandi D, Baradaran B, et al. Docosahexaenoic acid (DHA) and linoleic acid (LA) modulate the expression of breast cancer involved miRNAs in MDA-MB-231 cell line. Clinical Nutrition ESPEN. Elsevier BV; 2021; 10.1016/j.clnesp.2021.09.006
• Paclitaxel Chemotherapy Induces Long-Term Memory Impairment and Neuroinflammation in a Mouse Model of Breast Cancer Survivorship Cite
  Chung N, Chang A, Gillis R, Sloan E, Walker AK. Paclitaxel Chemotherapy Induces Long-Term Memory Impairment and Neuroinflammation in a Mouse Model of Breast Cancer Survivorship. Research Square Platform LLC; 2021; 10.21203/rs.3.rs-783452/v1
• Interactions of Some Chemotherapeutic Agents as Epirubicin, Gemcitabine and Paclitaxel in Multicomponent Systems Based on Orange Essential Oil Cite
  Samide A, Tutunaru B, Varut R, Oprea B, Iordache S. Interactions of Some Chemotherapeutic Agents as Epirubicin, Gemcitabine and Paclitaxel in Multicomponent Systems Based on Orange Essential Oil. Pharmaceuticals. MDPI AG; 2021; 14:619 10.3390/ph14070619
• Network pharmacology-based evaluation of natural compounds with paclitaxel for the treatment of metastatic breast cancer Cite
  Rathaur P, Soni MN, Gelat B, Rawal R, Pandya HA, Johar K. Network pharmacology-based evaluation of natural compounds with paclitaxel for the treatment of metastatic breast cancer. Toxicology and Applied Pharmacology. Elsevier BV; 2021;:115576 10.1016/j.taap.2021.115576
• Mechanism Underlying Resveratrol's Attenuation of Paclitaxel Cytotoxicity in Human Breast Cancer Cells: Role of the SIRT1-FOXO1-HER3 Signaling Pathway Cite
  Fukui M, Choi HJ, Wang P, Zhu BT. Mechanism Underlying Resveratrol's Attenuation of Paclitaxel Cytotoxicity in Human Breast Cancer Cells: Role of the SIRT1-FOXO1-HER3 Signaling Pathway. Cancer Treatment and Research Communications. Elsevier BV; 2021;:100386 10.1016/j.ctarc.2021.100386
• Ursolic Acid Reverses the Chemoresistance of Breast Cancer Cells to Paclitaxel by Targeting MiRNA-149-5p/MyD88 Cite
  Xiang F, Fan Y, Ni Z, Liu Q, Zhu Z, Chen Z, et al. Ursolic Acid Reverses the Chemoresistance of Breast Cancer Cells to Paclitaxel by Targeting MiRNA-149-5p/MyD88. Frontiers in Oncology. Frontiers Media SA; 2019; 9 10.3389/fonc.2019.00501
• Permanent hair loss associated with taxane chemotherapy use in breast cancer: A retrospective survey at two tertiary UK cancer centres Cite
  Chan J, Adderley H, Alameddine M, Armstrong A, Arundell D, Fox R, et al. Permanent hair loss associated with taxane chemotherapy use in breast cancer: A retrospective survey at two tertiary UK cancer centres. European Journal of Cancer Care. Wiley; 2020; 10.1111/ecc.13395
• Impact of Exercise on Chemotherapy Tolerance and Survival in Early-Stage Breast Cancer: A Nonrandomized Controlled Trial Cite
  Kirkham AA, Gelmon KA, Van Patten CL, Bland KA, Wollmann H, McKenzie DC, et al. Impact of Exercise on Chemotherapy Tolerance and Survival in Early-Stage Breast Cancer: A Nonrandomized Controlled Trial. Journal of the National Comprehensive Cancer Network. Harborside Press, LLC; 2020; 18:1670-1677 10.6004/jnccn.2020.7603
• Anacardic 6-pentadecyl salicylic acid induces apoptosis in breast cancer tumor cells, immunostimulation in the host and decreases blood toxic effects of taxol in an animal model Cite
  Gnanaprakasam JR, López-Bañuelos L, Vega L. Anacardic 6-pentadecyl salicylic acid induces apoptosis in breast cancer tumor cells, immunostimulation in the host and decreases blood toxic effects of taxol in an animal model. Toxicology and Applied Pharmacology. Elsevier BV; 2020; 410:115359 10.1016/j.taap.2020.115359
• Scalp Cooling Impact in Alopecia of Patients Under Treatment for Breast Cancer—Literature Review Cite
  Wiethan GÁ, Sari MHM, Ferreira LM. Scalp Cooling Impact in Alopecia of Patients Under Treatment for Breast Cancer—Literature Review. SN Comprehensive Clinical Medicine. Springer Science and Business Media LLC; 2020; 2:2825-2833 10.1007/s42399-020-00653-x
• Metformin induced lactic acidosis impaired response of cancer cells towards paclitaxel and doxorubicin: Role of monocarboxylate transporter Cite
  Singh SV, Chaube B, Mayengbam SS, Singh A, Malvi P, Mohammad N, et al. Metformin induced lactic acidosis impaired response of cancer cells towards paclitaxel and doxorubicin: Role of monocarboxylate transporter. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. Elsevier BV; 2020;:166011 10.1016/j.bbadis.2020.166011
• Gallic acid potentiates the apoptotic effect of paclitaxel and carboplatin via overexpression of Bax and P53 on the MCF‐7 human breast cancer cell line Cite
  Aborehab NM, Elnagar MR, Waly NE. Gallic acid potentiates the apoptotic effect of paclitaxel and carboplatin via overexpression of Bax and P53 on the MCF‐7 human breast cancer cell line. Journal of Biochemical and Molecular Toxicology. Wiley; 2020; 10.1002/jbt.22638
• Vitamin D-Induced Molecular Mechanisms to Potentiate Cancer Therapy and to Reverse Drug-Resistance in Cancer Cells Cite
  Negri M, Gentile A, de Angelis C, Montò T, Patalano R, Colao A, et al. Vitamin D-Induced Molecular Mechanisms to Potentiate Cancer Therapy and to Reverse Drug-Resistance in Cancer Cells. Nutrients. MDPI AG; 2020; 12:1798 10.3390/nu12061798
• Caffeine inhibits the anticancer activity of paclitaxel via down-regulation of α-tubulin acetylation Cite
  Xu H, Wang L, Shi B, Hu L, Gan C, Wang Y, et al. Caffeine inhibits the anticancer activity of paclitaxel via down-regulation of α-tubulin acetylation. Biomedicine & Pharmacotherapy. Elsevier BV; 2020; 129:110441 10.1016/j.biopha.2020.110441
• Paclitaxel-induced peripheral neuropathy in early-stage breast cancer patients. Cite
  Liu J, Sorooshian H. Paclitaxel-induced peripheral neuropathy in early-stage breast cancer patients.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2020; 38:e12503-e12503 10.1200/jco.2020.38.15_suppl.e12503
• Efficacy and safety of curcumin in combination with paclitaxel in patients with advanced, metastatic breast cancer: A comparative, randomized, double-blind, placebo-controlled clinical trial Cite
  Saghatelyan T, Tananyan A, Janoyan N, Tadevosyan A, Petrosyan H, Hovhannisyan A, et al. Efficacy and safety of curcumin in combination with paclitaxel in patients with advanced, metastatic breast cancer: A comparative, randomized, double-blind, placebo-controlled clinical trial. Phytomedicine. Elsevier BV; 2020; 70:153218 10.1016/j.phymed.2020.153218
• Ki-67 response-guided preoperative chemotherapy for HER2-positive breast cancer: results of a randomised Phase 2 study Cite
  Mukai H, Yamaguchi T, Takahashi M, Hozumi Y, Fujisawa T, Ohsumi S, et al. Ki-67 response-guided preoperative chemotherapy for HER2-positive breast cancer: results of a randomised Phase 2 study. British Journal of Cancer. Springer Science and Business Media LLC; 2020; 122:1747-1753 10.1038/s41416-020-0815-9
• Vitamin D deficiency increases severity of paclitaxel-induced peripheral neuropathy Cite
  Jennaro TS, Fang F, Kidwell KM, Smith EML, Vangipuram K, Burness ML, et al. Vitamin D deficiency increases severity of paclitaxel-induced peripheral neuropathy. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 180:707-714 10.1007/s10549-020-05584-8
• Thymoquinone Enhances Paclitaxel Anti-Breast Cancer Activity via Inhibiting Tumor-Associated Stem Cells Despite Apparent Mathematical Antagonism Cite
  Bashmail HA, Alamoudi AA, Noorwali A, Hegazy GA, Ajabnoor GM, Al-Abd AM. Thymoquinone Enhances Paclitaxel Anti-Breast Cancer Activity via Inhibiting Tumor-Associated Stem Cells Despite Apparent Mathematical Antagonism. Molecules. MDPI AG; 2020; 25:426 10.3390/molecules25020426
• Abstract 2995: Thymoquinone attenuates breast cancer cell resistance to paclitaxel via targeting tumor associated stem cell population Cite
  Bashmail HA, Alamoudi AA, Hegazy GA, Agabnoor GM, Noorwali A, Al-Abd AM. Abstract 2995: Thymoquinone attenuates breast cancer cell resistance to paclitaxel via targeting tumor associated stem cell population. Experimental and Molecular Therapeutics. American Association for Cancer Research; 2019; 10.1158/1538-7445.am2019-2995
• Potentiation of paclitaxel effect by resveratrol in human breast cancer cells by counteracting the 17β-estradiol/estrogen receptor α/neuroglobin pathway Cite
  Cipolletti M, Montalesi E, Nuzzo MT, Fiocchetti M, Ascenzi P, Marino M. Potentiation of paclitaxel effect by resveratrol in human breast cancer cells by counteracting the 17β-estradiol/estrogen receptor α/neuroglobin pathway. Journal of Cellular Physiology. Wiley; 2018; 234:3147-3157 10.1002/jcp.27309
• Risk factors for paclitaxel-induced peripheral neuropathy in patients with breast cancer Cite
  Ghoreishi Z, Keshavarz S, Asghari Jafarabadi M, Fathifar Z, Goodman KA, Esfahani A. Risk factors for paclitaxel-induced peripheral neuropathy in patients with breast cancer. BMC Cancer. Springer Science and Business Media LLC; 2018; 18 10.1186/s12885-018-4869-5
• Adipose-derived stem cell-mediated paclitaxel delivery inhibits breast cancer growth Cite
  Scioli MG, Artuso S, D'Angelo C, Porru M, D’Amico F, Bielli A, et al. Adipose-derived stem cell-mediated paclitaxel delivery inhibits breast cancer growth. PLOS ONE. Public Library of Science (PLoS); 2018; 13:e0203426 10.1371/journal.pone.0203426
• Effect of Vitamin D on Paclitaxel Efficacy in Triple-negative Breast Cancer Cell Lines Cite
  WILHELM CA, CLOR ZJ, KELTS JL. Effect of Vitamin D on Paclitaxel Efficacy in Triple-negative Breast Cancer Cell Lines. Anticancer Research. Anticancer Research USA Inc.; 2018; 38:5043-5048 10.21873/anticanres.12823
• Isobavachalcone sensitizes cells to E2-induced paclitaxel resistance by down-regulating CD44 expression in ER+ breast cancer cells Cite
  Shi J, Chen Y, Chen W, Tang C, Zhang H, Chen Y, et al. Isobavachalcone sensitizes cells to E2-induced paclitaxel resistance by down-regulating CD44 expression in ER+ breast cancer cells. Journal of Cellular and Molecular Medicine. Wiley; 2018; 22:5220-5230 10.1111/jcmm.13719
• Curcumin and paclitaxel induce cell death in breast cancer cell lines Cite
  Calaf G, Ponce-Cusi R, Carrion F. Curcumin and paclitaxel induce cell death in breast cancer cell lines. Oncology Reports. Spandidos Publications; 2018; 10.3892/or.2018.6603
• Abstract 5813: Thymoquinone influences the anticancer properties of paclitaxel and gemcitabine against breast cancer cells Cite
  Bashmil HA, Alamoudi AA, Noorwali A, Hegazy GA, Ajabnoor G, Al-Abd AM. Abstract 5813: Thymoquinone influences the anticancer properties of paclitaxel and gemcitabine against breast cancer cells. Experimental and Molecular Therapeutics. American Association for Cancer Research; 2018; 10.1158/1538-7445.am2018-5813
• High salt induces P-glycoprotein mediated treatment resistance in breast cancer cells through store operated calcium influx Cite
  Babaer D, Amara S, Ivy M, Zhao Y, Lammers PE, Titze JM, et al. High salt induces P-glycoprotein mediated treatment resistance in breast cancer cells through store operated calcium influx. Oncotarget. Impact Journals, LLC; 2018; 9:25193-25205 10.18632/oncotarget.25391
• Quercetin reversed MDR in breast cancer cells through down-regulating P-gp expression and eliminating cancer stem cells mediated by YB-1 nuclear translocation Cite
  Li S, Zhao Q, Wang B, Yuan S, Wang X, Li K. Quercetin reversed MDR in breast cancer cells through down-regulating P-gp expression and eliminating cancer stem cells mediated by YB-1 nuclear translocation. Phytotherapy Research. Wiley; 2018; 32:1530-1536 10.1002/ptr.6081
• Carotenoid Lutein Selectively Inhibits Breast Cancer Cell Growth and Potentiates the Effect of Chemotherapeutic Agents through ROS-Mediated Mechanisms Cite
  Gong X, Smith J, Swanson H, Rubin L. Carotenoid Lutein Selectively Inhibits Breast Cancer Cell Growth and Potentiates the Effect of Chemotherapeutic Agents through ROS-Mediated Mechanisms. Molecules. MDPI AG; 2018; 23:905 10.3390/molecules23040905
• Taxane acute pain syndrome (TAPS) in patients receiving chemotherapy for breast or prostate cancer: a prospective multi-center study Cite
  Fernandes R, Mazzarello S, Joy AA, Pond GR, Hilton J, Ibrahim MFK, et al. Taxane acute pain syndrome (TAPS) in patients receiving chemotherapy for breast or prostate cancer: a prospective multi-center study. Supportive Care in Cancer. Springer Science and Business Media LLC; 2018; 26:3073-3081 10.1007/s00520-018-4161-x
• Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy Cite
  Alemi A, Zavar Reza J, Haghiralsadat F, Zarei Jaliani H, Haghi Karamallah M, Hosseini SA, et al. Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy. Journal of Nanobiotechnology. Springer Science and Business Media LLC; 2018; 16 10.1186/s12951-018-0351-4
• Blockade of insulin-like growth factors increases efficacy of paclitaxel in metastatic breast cancer Cite
  Ireland L, Santos A, Campbell F, Figueiredo C, Hammond D, Ellies LG, et al. Blockade of insulin-like growth factors increases efficacy of paclitaxel in metastatic breast cancer. Oncogene. Springer Science and Business Media LLC; 2018; 37:2022-2036 10.1038/s41388-017-0115-x
• The Effects of Paclitaxel and Metformin and Combined Treatments on TLR Signaling Pathway on MDA-MB-231 Breast Cancer Cell Lines Cite
  Ozgul M, Uluer ET, Onal T, Akogullari D, Ozbilgin K, Inan S. The Effects of Paclitaxel and Metformin and Combined Treatments on TLR Signaling Pathway on MDA-MB-231 Breast Cancer Cell Lines. Proceedings. MDPI AG; 2017; 1:1016 10.3390/proceedings1101016
• Effects of Cryotherapy on Objective and Subjective Symptoms of Paclitaxel-Induced Neuropathy: Prospective Self-Controlled Trial Cite
  Hanai A, Ishiguro H, Sozu T, Tsuda M, Yano I, Nakagawa T, et al. Effects of Cryotherapy on Objective and Subjective Symptoms of Paclitaxel-Induced Neuropathy: Prospective Self-Controlled Trial. JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2017; 110:141-148 10.1093/jnci/djx178
• Melatonin limits paclitaxel-induced mitochondrial dysfunction in vitro and protects against paclitaxel-induced neuropathic pain in the rat Cite
  Galley HF, McCormick B, Wilson KL, Lowes DA, Colvin L, Torsney C. Melatonin limits paclitaxel-induced mitochondrial dysfunction in vitro and protects against paclitaxel-induced neuropathic pain in the rat. Journal of Pineal Research. Wiley; 2017; 63:e12444 10.1111/jpi.12444
• Stress-inducible gene Atf3 in the noncancer host cells contributes to chemotherapy-exacerbated breast cancer metastasis Cite
  Chang YS, Jalgaonkar SP, Middleton JD, Hai T. Stress-inducible gene Atf3 in the noncancer host cells contributes to chemotherapy-exacerbated breast cancer metastasis. Proceedings of the National Academy of Sciences. Proceedings of the National Academy of Sciences; 2017; 114:E7159-E7168 10.1073/pnas.1700455114
• Reversal of paclitaxel resistance in human ovarian cancer cells with redox-responsive micelles consisting of α-tocopheryl succinate-based polyphosphoester copolymers Cite
  Chen F, Zhang J, Fang X, Yu H, Liu Y, Li H, et al. Reversal of paclitaxel resistance in human ovarian cancer cells with redox-responsive micelles consisting of α-tocopheryl succinate-based polyphosphoester copolymers. Acta Pharmacologica Sinica. Springer Science and Business Media LLC; 2017; 38:859-873 10.1038/aps.2016.150
• Sulforaphane enhances the anticancer activity of taxanes against triple negative breast cancer by killing cancer stem cells Cite
  Burnett JP, Lim G, Li Y, Shah RB, Lim R, Paholak HJ, et al. Sulforaphane enhances the anticancer activity of taxanes against triple negative breast cancer by killing cancer stem cells. Cancer Letters. Elsevier BV; 2017; 394:52-64 10.1016/j.canlet.2017.02.023
• Role of Toll-like receptor 4 in drug-drug interaction between paclitaxel and irinotecan in vitro Cite
  Mallick P, Basu S, Moorthy B, Ghose R. Role of Toll-like receptor 4 in drug-drug interaction between paclitaxel and irinotecan in vitro. Toxicology in Vitro. Elsevier BV; 2017; 41:75-82 10.1016/j.tiv.2017.02.019
• Nicotinamide riboside, a form of vitamin B3 and NAD+ precursor, relieves the nociceptive and aversive dimensions of paclitaxel-induced peripheral neuropathy in female rats Cite
  Hamity MV, White SR, Walder RY, Schmidt MS, Brenner C, Hammond DL. Nicotinamide riboside, a form of vitamin B3 and NAD+ precursor, relieves the nociceptive and aversive dimensions of paclitaxel-induced peripheral neuropathy in female rats. PAIN. Ovid Technologies (Wolters Kluwer Health); 2017; 158:962-972 10.1097/j.pain.0000000000000862
• Effects of paclitaxel on the development of neuropathy and affective behaviors in the mouse Cite
  Toma W, Kyte SL, Bagdas D, Alkhlaif Y, Alsharari SD, Lichtman AH, et al. Effects of paclitaxel on the development of neuropathy and affective behaviors in the mouse. Neuropharmacology. Elsevier BV; 2017; 117:305-315 10.1016/j.neuropharm.2017.02.020
• Downregulation of importin-9 protects MCF-7 cells against apoptosis induced by the combination of garlic-derived alliin and paclitaxel Cite
  IZDEBSKA M, GRZANKA D, GAGAT M, HAŁAS-WIŚNIEWSKA M, GRZANKA A. Downregulation of importin-9 protects MCF-7 cells against apoptosis induced by the combination of garlic-derived alliin and paclitaxel. Oncology Reports. Spandidos Publications; 2016; 35:3084-3093 10.3892/or.2016.4628
• A Difference in the Incidences of Hypersensitivity Reactions to Original and Generic Taxanes Cite
  Ratanajarusiri T, Sriuranpong V, Sitthideatphaiboon P, Poovoravan N, Vinayanuwat C, Parinyanitikul N, et al. A Difference in the Incidences of Hypersensitivity Reactions to Original and Generic Taxanes. Chemotherapy. S. Karger AG; 2016; 62:134-139 10.1159/000450748
• Abstract 874: Circadian/melatonin disruption by dim light at night drives paclitaxel resistance in breast cancer via activation of stat3 Cite
  Hill SM, Xiang S, Dauchy RT, mao L, Yuan L, Hauch A, et al. Abstract 874: Circadian/melatonin disruption by dim light at night drives paclitaxel resistance in breast cancer via activation of stat3. Experimental and Molecular Therapeutics. American Association for Cancer Research; 2016; 10.1158/1538-7445.am2016-874
• Enhancing the Apoptotic Effect of a Low Dose of Paclitaxel on Tumor Cells in Mice by Arabinoxylan Rice Bran (MGN-3/Biobran)* Cite
  Badr El-Din NK, Ali DA, Alaa El-Dein M, Ghoneum M. Enhancing the Apoptotic Effect of a Low Dose of Paclitaxel on Tumor Cells in Mice by Arabinoxylan Rice Bran (MGN-3/Biobran)*. Nutrition and Cancer. Informa UK Limited; 2016; 68:1010-1020 10.1080/01635581.2016.1192204
• Ferulic acid reverses ABCB1-mediated paclitaxel resistance in MDR cell lines Cite
  Muthusamy G, Balupillai A, Ramasamy K, Shanmugam M, Gunaseelan S, Mary B, et al. Ferulic acid reverses ABCB1-mediated paclitaxel resistance in MDR cell lines. European Journal of Pharmacology. Elsevier BV; 2016; 786:194-203 10.1016/j.ejphar.2016.05.023
• Effects of Jia-Wei-Xiao-Yao-San on the Peripheral and Lymphatic Pharmacokinetics of Paclitaxel in Rats Cite
  Hou M, Lu C, Tsai T. Effects of Jia-Wei-Xiao-Yao-San on the Peripheral and Lymphatic Pharmacokinetics of Paclitaxel in Rats. Evidence-Based Complementary and Alternative Medicine. Hindawi Limited; 2016; 2016:1-10 10.1155/2016/5614747
• Combination Therapy using Co-encapsulated Resveratrol and Paclitaxel in Liposomes for Drug Resistance Reversal in Breast Cancer Cells in vivo Cite
  Meng J, Guo F, Xu H, Liang W, Wang C, Yang X. Combination Therapy using Co-encapsulated Resveratrol and Paclitaxel in Liposomes for Drug Resistance Reversal in Breast Cancer Cells in vivo. Scientific Reports. Springer Science and Business Media LLC; 2016; 6 10.1038/srep22390
• Paclitaxel and the dietary flavonoid fisetin: a synergistic combination that induces mitotic catastrophe and autophagic cell death in A549 non-small cell lung cancer cells Cite
  Klimaszewska-Wisniewska A, Halas-Wisniewska M, Tadrowski T, Gagat M, Grzanka D, Grzanka A. Paclitaxel and the dietary flavonoid fisetin: a synergistic combination that induces mitotic catastrophe and autophagic cell death in A549 non-small cell lung cancer cells. Cancer Cell International. Springer Science and Business Media LLC; 2016; 16 10.1186/s12935-016-0288-3
• Chemotherapy Agents Alter Plasma Lipids in Breast Cancer Patients and Show Differential Effects on Lipid Metabolism Genes in Liver Cells Cite
  Sharma M, Tuaine J, McLaren B, Waters DL, Black K, Jones LM, et al. Chemotherapy Agents Alter Plasma Lipids in Breast Cancer Patients and Show Differential Effects on Lipid Metabolism Genes in Liver Cells. PLOS ONE. Public Library of Science (PLoS); 2016; 11:e0148049 10.1371/journal.pone.0148049
• Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer Cite
  Dang C, Guo H, Najita J, Yardley D, Marcom K, Albain K, et al. Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer. JAMA Oncology. American Medical Association (AMA); 2016; 2:29 10.1001/jamaoncol.2015.3709
• Synergistic Apoptotic Effect of Crocin and Paclitaxel or Crocin and Radiation on MCF-7 Cells, a Type of Breast Cancer Cell Line Cite
  Vali F, Changizi V, Safa M. Synergistic Apoptotic Effect of Crocin and Paclitaxel or Crocin and Radiation on MCF-7 Cells, a Type of Breast Cancer Cell Line. International Journal of Breast Cancer. Hindawi Limited; 2015; 2015:1-7 10.1155/2015/139349
• Caffeine diminishes cytotoxic effects of paclitaxel on a human lung adenocarcinoma cell line Cite
  Kitamoto Y, Sakurai H, Mitsuhashi N, Akimoto T, Nakano T. Caffeine diminishes cytotoxic effects of paclitaxel on a human lung adenocarcinoma cell line. Cancer Letters. Elsevier BV; 2003; 191:101-107 10.1016/s0304-3835(02)00591-8
• Dual drug-loaded paclitaxel–thymoquinone nanoparticles for effective breast cancer therapy Cite
  Soni P, Kaur J, Tikoo K. Dual drug-loaded paclitaxel–thymoquinone nanoparticles for effective breast cancer therapy. Journal of Nanoparticle Research. Springer Science and Business Media LLC; 2015; 17 10.1007/s11051-014-2821-4
• Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance) Cite
  Ligibel JA, Cirrincione CT, Liu M, Citron M, Ingle JN, Gradishar W, et al. Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance). JNCI: Journal of the National Cancer Institute. Oxford University Press (OUP); 2015; 107 10.1093/jnci/djv179
• Combined effect of paclitaxel and piperine on a MCF-7 breast cancer cell line in vitro: Evidence of a synergistic interaction Cite
  Motiwala M, Rangari V. Combined effect of paclitaxel and piperine on a MCF-7 breast cancer cell line in vitro: Evidence of a synergistic interaction. Synergy. Elsevier BV; 2015; 2:1-6 10.1016/j.synres.2015.04.001
• Stress hormones reduce the efficacy of paclitaxel in triple negative breast cancer through induction of DNA damage Cite
  Reeder A, Attar M, Nazario L, Bathula C, Zhang A, Hochbaum D, et al. Stress hormones reduce the efficacy of paclitaxel in triple negative breast cancer through induction of DNA damage. British Journal of Cancer. Springer Science and Business Media LLC; 2015; 112:1461-1470 10.1038/bjc.2015.133
• Targeting Cancer Stem Cells in Breast Cancer: Potential Anticancer Properties of 6-Shogaol and Pterostilbene Cite
  Wu C, Hong B, Ho C, Yen G. Targeting Cancer Stem Cells in Breast Cancer: Potential Anticancer Properties of 6-Shogaol and Pterostilbene. Journal of Agricultural and Food Chemistry. American Chemical Society (ACS); 2015; 63:2432-2441 10.1021/acs.jafc.5b00002
• Salvianolic acid A reverses paclitaxel resistance in human breast cancer MCF-7 cells via targeting the expression of transgelin 2 and attenuating PI3 K/Akt pathway Cite
  Cai J, Chen S, Zhang W, Zheng X, Hu S, Pang C, et al. Salvianolic acid A reverses paclitaxel resistance in human breast cancer MCF-7 cells via targeting the expression of transgelin 2 and attenuating PI3 K/Akt pathway. Phytomedicine. Elsevier BV; 2014; 21:1725-1732 10.1016/j.phymed.2014.08.007
• Ototoxicity of paclitaxel in rat cochlear organotypic cultures Cite
  Dong Y, Ding D, Jiang H, Shi J, Salvi R, Roth JA. Ototoxicity of paclitaxel in rat cochlear organotypic cultures. Toxicology and Applied Pharmacology. Elsevier BV; 2014; 280:526-533 10.1016/j.taap.2014.08.022
• Low Concentration of Quercetin Antagonizes the Cytotoxic Effects of Anti-Neoplastic Drugs in Ovarian Cancer Cite
  Li N, Sun C, Zhou B, Xing H, Ma D, Chen G, et al. Low Concentration of Quercetin Antagonizes the Cytotoxic Effects of Anti-Neoplastic Drugs in Ovarian Cancer. PLoS ONE. Public Library of Science (PLoS); 2014; 9:e100314 10.1371/journal.pone.0100314
• Risk of Hospitalization According to Chemotherapy Regimen in Early-Stage Breast Cancer Cite
  Barcenas CH, Niu J, Zhang N, Zhang Y, Buchholz TA, Elting LS, et al. Risk of Hospitalization According to Chemotherapy Regimen in Early-Stage Breast Cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014; 32:2010-2017 10.1200/jco.2013.49.3676
• Luteolin enhances paclitaxel-induced apoptosis in human breast cancer MDA-MB-231 cells by blocking STAT3 Cite
  Yang M, Wang C, Chen N, Ho W, Lu F, Tseng T. Luteolin enhances paclitaxel-induced apoptosis in human breast cancer MDA-MB-231 cells by blocking STAT3. Chemico-Biological Interactions. Elsevier BV; 2014; 213:60-68 10.1016/j.cbi.2014.02.002
• Fucoidan extract enhances the anti-cancer activity of chemotherapeutic agents in breast cancer cells Cite
  Shirahata S, Zhang Z, Yoshida T, Eto H, Teruya K. Fucoidan extract enhances the anti-cancer activity of chemotherapeutic agents in breast cancer cells. BMC Proceedings. Springer Science and Business Media LLC; 2013; 7 10.1186/1753-6561-7-s6-p70
• Myricetin induces apoptosis and enhances chemosensitivity in ovarian cancer cells Cite
  Zheng A, Chen Y, Zhao L, Feng J. Myricetin induces apoptosis and enhances chemosensitivity in ovarian cancer cells. Oncology Letters. Spandidos Publications; 2017; 13:4974-4978 10.3892/ol.2017.6031
• Caffeine inhibits paclitaxel-induced apoptosis in colorectal cancer cells through the upregulation of Mcl-1 levels Cite
  MHAIDAT NM, ALZOUBI KH, AL-AZZAM SI, ALSAAD AA. Caffeine inhibits paclitaxel-induced apoptosis in colorectal cancer cells through the upregulation of Mcl-1 levels. Molecular Medicine Reports. Spandidos Publications; 2013; 9:243-248 10.3892/mmr.2013.1763
• Metformin reverses multidrug resistance and epithelial–mesenchymal transition (EMT) via activating AMP-activated protein kinase (AMPK) in human breast cancer cells Cite
  Qu C, Zhang W, Zheng G, Zhang Z, Yin J, He Z. Metformin reverses multidrug resistance and epithelial–mesenchymal transition (EMT) via activating AMP-activated protein kinase (AMPK) in human breast cancer cells. Molecular and Cellular Biochemistry. Springer Science and Business Media LLC; 2013; 386:63-71 10.1007/s11010-013-1845-x
• Antitumor efficacy of piperine in the treatment of human HER2-overexpressing breast cancer cells Cite
  Do MT, Kim HG, Choi JH, Khanal T, Park BH, Tran TP, et al. Antitumor efficacy of piperine in the treatment of human HER2-overexpressing breast cancer cells. Food Chemistry. Elsevier BV; 2013; 141:2591-2599 10.1016/j.foodchem.2013.04.125
• Breast Cancer and Obesity: In Vitro Interferences between Adipokines and Proangiogenic Features and/or Antitumor Therapies? Cite
  Dubois V, Delort L, Billard H, Vasson M, Caldefie-Chezet F. Breast Cancer and Obesity: In Vitro Interferences between Adipokines and Proangiogenic Features and/or Antitumor Therapies?. PLoS ONE. Public Library of Science (PLoS); 2013; 8:e58541 10.1371/journal.pone.0058541
• Obesity or Overweight Is Associated with Worse Pathological Response to Neoadjuvant Chemotherapy among Chinese Women with Breast Cancer Cite
  Chen S, Chen C, Zhou Y, Zhou R, Yu K, Shao Z. Obesity or Overweight Is Associated with Worse Pathological Response to Neoadjuvant Chemotherapy among Chinese Women with Breast Cancer. PLoS ONE. Public Library of Science (PLoS); 2012; 7:e41380 10.1371/journal.pone.0041380
• Diindolilmethane (DIM) selectively inhibits cancer stem cells Cite
  Semov A, Iourtchenco L, Lin Fang L, Shengmin L, Xu Y, Su X, et al. Diindolilmethane (DIM) selectively inhibits cancer stem cells. Biochemical and Biophysical Research Communications. Elsevier BV; 2012; 424:45-51 10.1016/j.bbrc.2012.06.062
• Abstract 5676: Effects of resveratrol on paclitaxel-sensitive and -resistant triple negative breast cancer cells Cite
  Sprouse AA, Herbert B. Abstract 5676: Effects of resveratrol on paclitaxel-sensitive and -resistant triple negative breast cancer cells. Experimental and Molecular Therapeutics. American Association for Cancer Research; 2012; 10.1158/1538-7445.am2012-5676
• (-)-Epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinoma Cite
  Luo T, Wang J, Yin Y, Hua H, Jing J, Sun X, et al. (-)-Epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinoma. Breast Cancer Research. Springer Science and Business Media LLC; 2010; 12 10.1186/bcr2473
• Methylseleninic Acid Enhances Paclitaxel Efficacy for the Treatment of Triple-Negative Breast Cancer Cite
  Qi Y, Fu X, Xiong Z, Zhang H, Hill SM, Rowan BG, et al. Methylseleninic Acid Enhances Paclitaxel Efficacy for the Treatment of Triple-Negative Breast Cancer. PLoS ONE. Public Library of Science (PLoS); 2012; 7:e31539 10.1371/journal.pone.0031539
• Synergistic Effects of Apigenin and Paclitaxel on Apoptosis of Cancer Cells Cite
  Xu Y, Xin Y, Diao Y, Lu C, Fu J, Luo L, et al. Synergistic Effects of Apigenin and Paclitaxel on Apoptosis of Cancer Cells. PLoS ONE. Public Library of Science (PLoS); 2011; 6:e29169 10.1371/journal.pone.0029169
• Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment Cite
  Pasquier E, Ciccolini J, Carre M, Giacometti S, Fanciullino R, Pouchy C, et al. Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment. Oncotarget. Impact Journals, LLC; 2011; 2:797-809 10.18632/oncotarget.343
• Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline- and nonanthracycline-based regimens for HER2-positive breast cancer Cite
  Bayraktar S, Gonzalez-Angulo AM, Lei X, Buzdar AU, Valero V, Melhem-Bertrandt A, et al. Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline- and nonanthracycline-based regimens for HER2-positive breast cancer. Cancer. Wiley; 2011; 118:2385-2393 10.1002/cncr.26555
• Late pancreatic toxicity in patients with breast cancer after taxane-anthracycline–based neoadjuvant and adjuvant chemotherapy. Cite
  Kopp MV, Koroleva I, Kasulin AN, Kucheryavyy JA, Byakhov MJ. Late pancreatic toxicity in patients with breast cancer after taxane-anthracycline–based neoadjuvant and adjuvant chemotherapy.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010; 28:e11043-e11043 10.1200/jco.2010.28.15_suppl.e11043
• The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer Cite
  Abusief ME, Missmer SA, Ginsburg ES, Weeks JC, Partridge AH. The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer. Cancer. Wiley; 2010; 116:791-798 10.1002/cncr.24835
• Apple polyphenol phloretin potentiates the anticancer actions of paclitaxel through induction of apoptosis in human hep G2 cells Cite
  Yang K, Tsai C, Wang Y, Wei P, Lee C, Chen J, et al. Apple polyphenol phloretin potentiates the anticancer actions of paclitaxel through induction of apoptosis in human hep G2 cells. Molecular Carcinogenesis. Wiley; 2009; 48:420-431 10.1002/mc.20480
• 3,3′-Diindolylmethane and Paclitaxel Act Synergistically to Promote Apoptosis in HER2/Neu Human Breast Cancer Cells Cite
  McGuire K, Ngoubilly N, Neavyn M, Lanza-Jacoby S. 3,3′-Diindolylmethane and Paclitaxel Act Synergistically to Promote Apoptosis in HER2/Neu Human Breast Cancer Cells. Journal of Surgical Research. Elsevier BV; 2006; 132:208-213 10.1016/j.jss.2006.02.008
• EGCG Stabilizes p27kip1 in E2-Stimulated MCF-7 Cells through Down-Regulation of the Skp2 Protein Cite
  Huang H, Way T, Lin C, Lin J. EGCG Stabilizes p27kip1 in E2-Stimulated MCF-7 Cells through Down-Regulation of the Skp2 Protein. Endocrinology. The Endocrine Society; 2008; 149:5972-5983 10.1210/en.2008-0408
• Exogenous supplementation with ω-3 polyunsaturated fatty acid docosahexaenoic acid (DHA; 22:6n-3) synergistically enhances taxane cytotoxicity and downregulates Her-2/neu (c-erbB-2) oncogene expression in human breast cancer cells Cite
  Menendez JA, Lupu R, Colomer R. Exogenous supplementation with ω-3 polyunsaturated fatty acid docosahexaenoic acid (DHA; 22:6n-3) synergistically enhances taxane cytotoxicity and downregulates Her-2/neu (c-erbB-2) oncogene expression in human breast cancer cells. European Journal of Cancer Prevention. Ovid Technologies (Wolters Kluwer Health); 2005; 14:263-270 10.1097/00008469-200506000-00011
• Suppression of microtubule dynamic instability and turnover in MCF7 breast cancer cells by sulforaphane Cite
  Azarenko O, Okouneva T, Singletary KW, Jordan MA, Wilson L. Suppression of microtubule dynamic instability and turnover in MCF7 breast cancer cells by sulforaphane. Carcinogenesis. Oxford University Press (OUP); 2008; 29:2360-2368 10.1093/carcin/bgn241
• Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells Cite
  Menéndez J, del Mar Barbacid M, Montero S, Sevilla E, Escrich E, Solanas M, et al. Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells. European Journal of Cancer. Elsevier BV; 2001; 37:402-413 10.1016/s0959-8049(00)00408-1